Aortic stiffness is associated with elevated high-sensitivity cardiac troponin T concentrations at a chronic stage

Hans-Josef Feistritzer1, Gert Klug, Sebastian J Reinstadler

  • 1aUniversity Clinic of Internal Medicine III, Cardiology and Angiology bUniversity Clinic of Radiology, Medical University of Innsbruck, Anichstrasse 35, Innsbruck, Austria.

Insights

Aortic stiffness, measured by aortic pulse wave velocity (PWV), is linked to elevated high-sensitivity cardiac troponin T (hs-TnT) levels long after ST-segment elevation myocardial infarction (STEMI). This finding highlights a potential marker for cardiac damage in chronic STEMI patients.

Area of Science:

  • Cardiology
  • Biomarkers
  • Vascular Physiology

Background:

  • Aortic stiffness, assessed by aortic pulse wave velocity (PWV), is crucial for evaluating left ventricular afterload and coronary perfusion.
  • Subclinical elevation of high-sensitivity cardiac troponin T (hs-TnT) may indicate ongoing myocardial damage.
  • Understanding the relationship between aortic stiffness and hs-TnT post-ST-segment elevation myocardial infarction (STEMI) is important for long-term patient management.

Purpose of the Study:

  • To investigate the association between aortic PWV and hs-TnT concentrations in patients at a chronic stage after acute STEMI.
  • To determine if aortic stiffness is an independent predictor of elevated hs-TnT levels in this population.

Main Methods:

  • A cross-sectional study involving 74 patients 12 months post-STEMI.
  • Cardiac MRI was used to assess left ventricular function, morphology, infarct size, and aortic PWV.
  • Peripheral blood samples were analyzed for hs-TnT levels using a commercial immunoassay.

Main Results:

  • Aortic PWV showed a significant positive association with hs-TnT concentrations (r=0.435, P<0.001).
  • Multiple linear regression analysis confirmed that aortic PWV was independently associated with hs-TnT levels (ß=0.330, P=0.025), even after adjusting for plasma creatinine.
  • hs-TnT levels also correlated significantly with age, plasma creatinine, and high-sensitivity C-reactive protein.

Conclusions:

  • Aortic stiffness is associated with elevated hs-TnT concentrations in the chronic phase following STEMI.
  • These findings suggest that aortic stiffness may serve as a marker for subclinical myocardial injury in long-term STEMI survivors.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.7K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
456
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
929
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
767
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
472